Prestige Consumer Healthcare (PBH) Competitors

Inter Parfums (NASDAQ:IPAR) and Prestige Consumer Healthcare (NYSE:PBH) are both mid-cap consumer staples companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.

Do analysts rate IPAR or PBH?

Inter Parfums currently has a consensus price target of $178.67, suggesting a potential upside of 49.16%. Prestige Consumer Healthcare has a consensus price target of $91.25, suggesting a potential upside of 41.89%. Given Prestige Consumer Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prestige Consumer Healthcare	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has more risk & volatility, IPAR or PBH?

Inter Parfums has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Prestige Consumer Healthcare has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in IPAR or PBH?

55.6% of Inter Parfums shares are owned by institutional investors. Comparatively, 99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. 43.9% of Inter Parfums shares are owned by company insiders. Comparatively, 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Is IPAR or PBH a better dividend stock?

Inter Parfums pays an annual dividend of $3.00 per share and has a dividend yield of 2.5%. Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 3.0%. Inter Parfums pays out 69.1% of its earnings in the form of a dividend. Prestige Consumer Healthcare pays out 45.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Inter Parfums has raised its dividend for 3 consecutive years. Prestige Consumer Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

Which has higher earnings and valuation, IPAR or PBH?

Prestige Consumer Healthcare has lower revenue, but higher earnings than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inter Parfums	$1.33B	2.88	$152.65M	$4.34	27.60
Prestige Consumer Healthcare	$1.13B	2.85	$209.34M	$4.17	15.42

Does the MarketBeat Community prefer IPAR or PBH?

Prestige Consumer Healthcare received 38 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.70% of users gave Prestige Consumer Healthcare an outperform vote while only 64.32% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Inter Parfums	Outperform Votes 447 64.32%	Underperform Votes 248 35.68%
Prestige Consumer Healthcare	Outperform Votes 485 70.70%	Underperform Votes 201 29.30%

Is IPAR or PBH more profitable?

Prestige Consumer Healthcare has a net margin of 18.60% compared to Prestige Consumer Healthcare's net margin of 10.50%. Prestige Consumer Healthcare's return on equity of 15.85% beat Inter Parfums' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inter Parfums	10.50%	15.85%	10.22%
Prestige Consumer Healthcare	18.60%	13.48%	6.34%

Does the media refer more to IPAR or PBH?

In the previous week, Inter Parfums had 5 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 6 mentions for Inter Parfums and 1 mentions for Prestige Consumer Healthcare. Inter Parfums' average media sentiment score of 1.91 beat Prestige Consumer Healthcare's score of 0.58 indicating that Prestige Consumer Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inter Parfums	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prestige Consumer Healthcare	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Inter Parfums beats Prestige Consumer Healthcare on 13 of the 21 factors compared between the two stocks.